336 related articles for article (PubMed ID: 19442540)
1. In vitro effects of detergent sclerosants on antithrombotic mechanisms.
Parsi K; Exner T; Low J; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2009 Aug; 38(2):220-8. PubMed ID: 19442540
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles.
Parsi K; Exner T; Connor DE; Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):731-40. PubMed ID: 17919946
[TBL] [Abstract][Full Text] [Related]
3. In vitro effects of detergent sclerosants on clot formation and fibrinolysis.
Parsi K; Exner T; Low J; Fung Ma DD; Joseph JE
Eur J Vasc Endovasc Surg; 2011 Feb; 41(2):267-77. PubMed ID: 21183368
[TBL] [Abstract][Full Text] [Related]
4. In vitro effects of detergent sclerosants on fibrinolytic enzymes and inhibitors.
Parsi K; Exner T; Ma DD; Joseph JE
Thromb Res; 2010 Oct; 126(4):328-36. PubMed ID: 20682454
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant property of a semi-synthesized sodium beta-1,4-glucan sulfate.
Wang ZM; Li L; Li B; Guo SY
Yao Xue Xue Bao; 2006 Apr; 41(4):323-7. PubMed ID: 16856476
[TBL] [Abstract][Full Text] [Related]
6. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
7. Detergent Sclerosants Stimulate Leukocyte Apoptosis and Oncosis.
Cooley-Andrade O; Goh WX; Connor DE; Ma DD; Parsi K
Eur J Vasc Endovasc Surg; 2016 Jun; 51(6):846-56. PubMed ID: 27067723
[TBL] [Abstract][Full Text] [Related]
8. Effects of nadroparin, enoxaparin, and unfractionated heparin on endogenous formation of factor Xa and IIa and on thrombelastometry profiles in cord versus adult blood.
Cvirn G; Hoerl G; Tafeit E; Heinl N; Wodrig K; Wagner T; Koestenberger M; Juergens G
Neonatology; 2011; 100(1):23-31. PubMed ID: 21150227
[TBL] [Abstract][Full Text] [Related]
9. Detergent sclerosants are deactivated and consumed by circulating blood cells.
Connor DE; Cooley-Andrade O; Goh WX; Ma DD; Parsi K
Eur J Vasc Endovasc Surg; 2015 Apr; 49(4):426-31. PubMed ID: 25686663
[TBL] [Abstract][Full Text] [Related]
10. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
11. Preparation and anticoagulation activity of sodium cellulose sulfate.
Wang ZM; Li L; Zheng BS; Normakhamatov N; Guo SY
Int J Biol Macromol; 2007 Oct; 41(4):376-82. PubMed ID: 17602735
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
Johnstone IB; Martin CA
Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
[TBL] [Abstract][Full Text] [Related]
13. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
Fonseca RJ; Mourão PA
Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
[TBL] [Abstract][Full Text] [Related]
14. Biomarkers and coagulation tests for assessing the biosimilarity of a generic low-molecular-weight heparin: results of a study in healthy subjects with enoxaparin.
Kuczka K; Harder S; Picard-Willems B; Warnke A; Donath F; Bianchini P; Parma B; Blume H
J Clin Pharmacol; 2008 Oct; 48(10):1189-96. PubMed ID: 18716314
[TBL] [Abstract][Full Text] [Related]
15. The APTT response of pregnant plasma to unfractionated heparin.
Chunilal SD; Young E; Johnston MA; Robertson C; Naguit I; Stevens P; Galashan D; Oskamp ML; Brennan B; Ginsberg JS
Thromb Haemost; 2002 Jan; 87(1):92-7. PubMed ID: 11848463
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the anticoagulant activity of protein S by prothrombin.
Mitchell CA; Jane SM; Salem HH
J Clin Invest; 1988 Dec; 82(6):2142-7. PubMed ID: 2974048
[TBL] [Abstract][Full Text] [Related]
17. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
18. LIPIODOL reduces the lytic activity of detergent sclerosants
Gracé J; Connor D; Bester L; Rogan C; Parsi K
Phlebology; 2021 Dec; 36(10):771-778. PubMed ID: 34039085
[TBL] [Abstract][Full Text] [Related]
19. beta 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface.
Mori T; Takeya H; Nishioka J; Gabazza EC; Suzuki K
Thromb Haemost; 1996 Jan; 75(1):49-55. PubMed ID: 8713779
[TBL] [Abstract][Full Text] [Related]
20. Detecting APC-resistant factor V: a functional method without plasma dilution.
Rylatt DB; Hohnen-Behrens C; Pilgrim RL; Dickeson LE; Neal M; Exner T
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):359-66. PubMed ID: 10493217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
